Cleared Special

K060727 - VECTORVISION HIP

K060727 is an FDA 510(k) clearance for VECTORVISION HIP, manufactured by Brainlab AG. The device is a Class 2 Neurology device with product code HAW cleared through the Special 510(k) pathway after a 157-day FDA review.

K060727 · Brainlab AG · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2006
Decision
157d
Days
Class 2
Risk

K060727 is an FDA 510(k) clearance for the VECTORVISION HIP. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Brainlab AG (Heimstetten, DE). The FDA issued a Cleared decision on August 21, 2006 after a review of 157 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K060727

510(k) Number K060727 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 2006
Decision Date August 21, 2006
Days to Decision 157 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 149d · This submission: 157d
Pathway characteristics
Modification to existing cleared device.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 426
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K060727.
NAVIVISION
K062086 · Brainlab AG · Sep 2006
LAPDOC I
K061224 · Robodent GmbH · Sep 2006
AXIEM IMAGELESS HIP MODULE FOR THE STEALTHSTATION SYSTEM
K061248 · Medtronic Navigation, Inc. · Aug 2006
UNI KNEE SURGETICS NAVIGATION SYSTEM
K062146 · Praxim S.A · Aug 2006
STRYKER ORTHOPAEDICS RFID INSTRUMENTATION
K053348 · Howmedica Osteonics Corp. · Aug 2006
BRIGIT SURGICAL DEVICE
K060556 · Zimmer, Inc. · Jul 2006
K060727 · VECTORVISION HIP
Download PDF FDA Summary Brainlab AG